Integra LifeSciences (IART)
(Delayed Data from NSDQ)
$17.40 USD
-0.07 (-0.40%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $17.40 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value D Growth A Momentum C VGM
Price, Consensus and EPS Surprise
IART 17.40 -0.07(-0.40%)
Will IART be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IART based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IART
Integra's (IART) Q2 Earnings and Revenues Top, Margins Down
Compared to Estimates, Integra (IART) Q2 Earnings: A Look at Key Metrics
IART: What are Zacks experts saying now?
Zacks Private Portfolio Services
Integra LifeSciences (IART) Q2 Earnings and Revenues Surpass Estimates
Inari Medical, Inc. (NARI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Earnings Preview: Integra LifeSciences (IART) Q2 Earnings Expected to Decline
Other News for IART
Catalyst Watch: Spotlight on Micron, Southwest Airlines, and FOMC speakers
Integra Lifesciences Holdings Corp (IART) Trading Down 3.56% on Sep 11
Integra Lifesciences: Hold Rating Amidst Compliance Challenges and Revenue Impact with a Long-Term Recovery Outlook
Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference
Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference